RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy.

Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy.

Add to Collection
2014 Jun Others A Kumar - Expert opinion on biological therapy, 2014 - Taylor & Francis

Full Author : ['Kumar, Ajay']
Journal Title : Expert opinion on biological therapy
Chapter : Section3, Section5
Journal Year : 2014
Cited by : 19

INTRODUCTION: Existing pharmacological therapies with basal insulins are limited by weight gain and hypoglycemia, while those with glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are limited by issues of efficacy when used alone. However, when use..... Read More

Keywords : ['insulin degludecliraglutide innovationdriven combination', 'diabetes therapy', 'advancement']
PubMed Link : https://www.tandfonline.com/doi/abs/10.1517/14712598.2014.904851
Google Scholar Link : https://scholar.google.com/scholar?cites=3873662144252761172&as_sdt=4000005&sciodt=0,18&hl=en&num=20